BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14991573)

  • 1. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo.
    Morita T; Shibata K; Kikkawa F; Kajiyama H; Ino K; Mizutani S
    Int J Cancer; 2004 Apr; 109(4):525-32. PubMed ID: 14991573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.
    Cassoni P; Fulcheri E; Carcangiu ML; Stella A; Deaglio S; Bussolati G
    J Pathol; 2000 Mar; 190(4):470-7. PubMed ID: 10699997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitro.
    Mankarious A; Dave F; Pados G; Tsolakidis D; Gidron Y; Pang Y; Thomas P; Hall M; Karteris E
    Int J Oncol; 2016 May; 48(5):1805-14. PubMed ID: 26935408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin receptor within the breast: biological function and distribution.
    Sapino A; Cassoni P; Stella A; Bussolati G
    Anticancer Res; 1998; 18(3C):2181-6. PubMed ID: 9703781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J; Wang B
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling.
    PĂ©queux C; Breton C; Hendrick JC; Hagelstein MT; Martens H; Winkler R; Geenen V; Legros JJ
    Cancer Res; 2002 Aug; 62(16):4623-9. PubMed ID: 12183418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.
    Novak JF; Judkins MB; Chernin MI; Cassoni P; Bussolati G; Nitche JA; Nishimoto SK
    Cancer Res; 2000 Jul; 60(13):3470-6. PubMed ID: 10910058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel biological aspect of ovarian oxytocin: gene expression of oxytocin and oxytocin receptor in cumulus/luteal cells and the effect of oxytocin on embryogenesis in fertilized oocytes.
    Furuya K; Mizumoto Y; Makimura N; Mitsui C; Murakami M; Tokuoka S; Ishikawa N; Nagata I; Kimura T; Ivell R
    Adv Exp Med Biol; 1995; 395():523-8. PubMed ID: 8714009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors.
    Cassoni P; Marrocco T; Deaglio S; Sapino A; Bussolati G
    Ann Oncol; 2001; 12 Suppl 2():S37-9. PubMed ID: 11762350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.
    Hashimoto K; Morishige K; Sawada K; Tahara M; Kawagishi R; Ikebuchi Y; Sakata M; Tasaka K; Murata Y
    Cancer Res; 2005 Jan; 65(2):540-5. PubMed ID: 15695397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of oxytocin and its receptor in the local regulation of prostaglandin secretion in the cat endometrium.
    Siemieniuch MJ; Mlynarczuk JJ; Skarzynski DJ; Okuda K
    Anim Reprod Sci; 2011 Jan; 123(1-2):89-97. PubMed ID: 21129864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
    Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
    Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The regulation of human myometrial oxytocin receptor expression by oxytocin].
    Adachi S; Oku M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):87-93. PubMed ID: 7706861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity.
    Rosanò L; Di Castro V; Spinella F; Tortora G; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Jul; 67(13):6351-9. PubMed ID: 17616694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of stem cells by oxytocin to improve their therapeutic potential.
    Noiseux N; Borie M; Desnoyers A; Menaouar A; Stevens LM; Mansour S; Danalache BA; Roy DC; Jankowski M; Gutkowska J
    Endocrinology; 2012 Nov; 153(11):5361-72. PubMed ID: 23024264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas.
    Cassoni P; Marrocco T; Sapino A; Allia E; Bussolati G
    Int J Oncol; 2004 Oct; 25(4):899-904. PubMed ID: 15375538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines.
    Cassoni P; Sapino A; Munaron L; Deaglio S; Chini B; Graziani A; Ahmed A; Bussolati G
    Endocrinology; 2001 Mar; 142(3):1130-6. PubMed ID: 11181528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits the development and metastasis of ovarian cancer.
    Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
    Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.